Eligible Development Expenses definition

Eligible Development Expenses means all FTE Costs and Out-of-Pocket Expenses to the extent relating to the Territory (1) incurred by or on behalf of a Party or its Affiliates that are directly attributable or reasonably allocable to (x) Development activities in accordance with the Development Plan and Development Budget or (y) regulatory activities in accordance with the Regulatory Plan and Regulatory Budget, or (2) otherwise approved by the PCC, including the following:
Eligible Development Expenses means, on a Licensed Category 1 Target‑by‑Licensed Category 1 Target basis, the Development Expenses for such Licensed Category 1 Target [***]. Eligible Development Expenses will also include any [***]. Eligible Development Expenses specifically exclude any costs or expenses of a Party or its Affiliates to the extent [***]. No expense included as an Eligible Development Expense will also be included as an Eligible Commercialization Expense.
Eligible Development Expenses means, with respect to a Profit-Share Product and a period of the PSP P&L Share for such Profit-Share Product, all FTE Costs, Out-of-Pocket Costs, and other costs and expenses incurred by or on behalf of a Party or its Affiliates that are directly attributable to Development activities for such Profit-Share Product in accordance with the applicable Co-Funded Development Plan, including the following:

Examples of Eligible Development Expenses in a sentence

  • Commencing from and after the Execution Date and during the Term, the Parties will share all Eligible Development Expenses [***] at a ratio of [***] (Takeda: Arrowhead) (the “Eligible Development Costs Share Ratio”) in accordance with [***].

  • On a Licensed Category 1 Target‑by‑Licensed Category 1 Target basis, Takeda and Wave US will share equally (50%/50%) in the total Eligible Development Expenses incurred by the Parties and their Affiliates with respect to such Licensed Category 1 Target in accordance with the procedures set forth in this Section 11.3.2 (Eligible Development Expenses for Licensed Category 1 Targets).

  • On a Calendar Year basis, if the Eligible Development Expenses or Allowable Expenses incurred by a Party are in excess of the Global Development Plan/Budget or Co-Commercialization Plan/Budget, then such excess amounts may be included in calculating the amount of Reimbursable Development Expenses or Reimbursable Expenses, as applicable, incurred in such Calendar Year and to be shared by the Parties only to the extent that such amounts constitute Allowable Overruns for such Calendar Year.

  • For the sake of clarity, all Eligible Development Expenses incurred thereafter by the Parties in performing such Clinical Study (that was formerly the Independent Study) shall be shared as part of the Cost-Profit Share unless and until a Denali Opt-Out occurs with respect to the Licensed Product that is the subject of such Clinical Study and the Co-Funding End Date occurs.

  • In addition to the annual approval of the Global Development Budget, prior to the end of each Calendar Year, each Party will provide the Finance Working Group with a non-binding estimate of its Eligible Development Expenses for the next [***] Calendar Years (detailed on a Calendar Year basis) and the Parties shall review and discuss such estimated costs through the Finance Working Group or the JSC.

  • Each Party will keep (and will cause its Affiliates and Sublicensees to keep) complete and accurate records in accordance with the applicable Accounting Standards in relation to this Agreement, including in relation to all amounts relevant to the calculation of Eligible Development Expenses, Operating Profits or Losses and Net Sales.

  • Thereafter, so long as any Party incurs any Eligible Development Expenses, each such Party shall submit to the other Party: (i) within [***] after the end of each Calendar Quarter in which such Party or its Affiliates performs Development activities under the Global Development Plan/Budget, [***]; and (ii) [***]; provided that, with respect to Denali and the first Calendar Quarter following the Effective Date or in which the Effective Date occurs, such actual and estimate reports shall also include [***].

  • For clarity, Biogen shall not have the right under this Section 6.5.2(c) (Cost Sharing) to offset any amounts paid by Biogen that are shared by the Parties as Eligible Development Expenses or Allowable Expenses, as described above.

  • Eligible Development Expenses and each category of Allowable Expenses shall also exclude any costs [***] a breach of this Agreement by either Party.

  • So long as any Party incurs Eligible Development Expenses, Biogen will also submit to Denali, within [***] after the end of each Calendar Quarter, a written report of the total Reimbursable Development Expenses of both Parties for such Calendar Quarter (“Development Expense Report”).


More Definitions of Eligible Development Expenses

Eligible Development Expenses. MEANS, ON A LICENSED CATEGORY 1 TARGET‑BY‑LICENSED CATEGORY 1 TARGET BASIS, THE DEVELOPMENT EXPENSES FOR SUCH LICENSED CATEGORY 1 TARGET [***]. ELIGIBLE DEVELOPMENT EXPENSES WILL ALSO INCLUDE ANY [***]. ELIGIBLE DEVELOPMENT EXPENSES SPECIFICALLY EXCLUDE ANY COSTS OR EXPENSES OF A PARTY OR ITS AFFILIATES TO THE EXTENT [***]. NO EXPENSE INCLUDED AS AN ELIGIBLE DEVELOPMENT EXPENSE WILL ALSO BE INCLUDED AS AN ELIGIBLE COMMERCIALIZATION Expense.
Eligible Development Expenses means, with respect to all Licensed Products that are Cost-Profit Sharing Products (and all Licensed Compounds included in such Licensed Products), costs and expenses incurred by or on behalf of a Party or its Affiliates [***] such Licensed Products in accordance with the Global Development Plan/Budget or otherwise provided in Section 12.3 (Certain Indemnified Losses), as applicable:

Related to Eligible Development Expenses

  • Development Expenses means, with respect to SAIL Developments as well as HOME Developments when the HOME Development is also at least partially financed with a MMRB Loan (as defined in rule Chapter 67-21, F.A.C.), usual and customary operating and financial costs, such as the compliance monitoring fee, the financial monitoring fee, replacement reserves, the servicing fee and the debt service reserves. As it relates to SAIL Developments as well as HOME Developments when the HOME Development is also at least partially financed with a MMRB Loan (as defined in rule Chapter 67-21, F.A.C.) and to the application of Development Cash Flow described in subsections 67-48.010(5) and (6), F.A.C., as it relates to SAIL Developments or in paragraph 67-48.020(3)(b), F.A.C., as it relates to HOME Developments, the term includes only those expenses disclosed in the operating pro forma on an annual basis included in the final credit underwriting report, as approved by the Board, and maximum of 20 percent Developer Fee per year.

  • Development Costs means costs incurred to obtain access to reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas from reserves. More specifically, development costs, including applicable operating costs of support equipment and facilities and other costs of development activities, are costs incurred to:

  • Program Expenses means all UHC’s expenses of administering the Program under the Indenture and the Act and shall include without limiting the generality of the foregoing; salaries, supplies, utilities, labor, materials, office rent, maintenance, furnishings, equipment, machinery and apparatus, including information processing equipment; software, insurance premiums, credit enhancement fees, legal, accounting, management, consulting and banking services and expenses; Fiduciary Expenses; remarketing fees; Costs of Issuance not paid from proceeds of Bonds; and payments to pension, retirement, health and hospitalization funds; and any other expenses required or permitted to be paid by UHC.

  • Marketing Expenses mean the sum of Marketing Management Expenses, Advertising and Market Research Expenses and Medical Education Expenses.

  • Gross Operating Expenses shall include (i) all costs and expenses of operating the Hotel included within the meaning of the term “Total Costs and Expenses” contained in the Uniform System and, (ii) without duplication, the following: all salaries and employee expense and payroll taxes (including salaries, wages, bonuses and other compensation of all employees of the Hotel, and benefits including life, medical and disability insurance and retirement benefits), expenditures described in Section 9.1, operational supplies, utilities, insurance to be provided by Lessee under the terms of this Lease, governmental fees and assessments, common area maintenance costs and other common area fees and assessments, food, beverages, laundry service expense, the cost of Inventories, license fees, advertising, marketing, reservation systems and any and all other operating expenses as are reasonably necessary for the proper and efficient operation of the Hotel and the Leased Property incurred by Lessee in accordance with the provisions hereof (excluding, however, (i) federal, state and municipal excise, sales and use taxes collected directly from patrons and guests or as a part of the sales price of any goods, services or displays, such as gross receipts, admissions, cabaret or similar or equivalent taxes paid over to federal, state or municipal governments, (ii) the cost of insurance to be provided under Article 13, (iii) expenditures by Lessor pursuant to Article 13 and (iv) payments on any Mortgage or other mortgage or security instrument on the Hotel); all determined in accordance with generally accepted accounting principles. No part of Lessee’s central office overhead or general or administrative expense (as opposed to that of the Hotel), and no operating expenses paid or payable by tenants under Space Leases, shall be deemed to be a part of Gross Operating Expenses, as herein provided. Reasonable out-of-pocket expenses of Lessee incurred for the account of or in connection with the Hotel operations, including but not limited to postage, telephone charges and reasonable travel expenses of employees, officers and other representatives and consultants of Lessee and its Affiliates, shall be deemed to be a part of Gross Operating Expenses and such Persons shall be afforded reasonable accommodations, food, beverages, laundry, valet and other such services by and at the Hotel without charge to such Persons or Lessee.

  • Commercialization Costs means the sum of the following costs and expenses incurred by the Parties or their respective Affiliates, in Commercializing the Shared Products (and related Manufacturing activities) in the Territory, in each case, to the extent incurred in accordance with the Commercialization Plan and Commercialization Budget:

  • Patent Expenses means all reasonable costs (including attorneys’ and application fees) incurred by University in accordance with this Agreement to apply for, prosecute and maintain Licensed Patents, including but not limited to the costs of interferences, oppositions, inter partes review and re-examinations. Patent Expenses include reimbursement for in-house costs provided they are for activities that would otherwise have been performed by outside counsel at an equal or greater expense.

  • medium term expenditure framework ’ means a budgeting framework applied by the National Treasury which—

  • Covered Expenses means expenses actually incurred by or on behalf of a Covered Person for treatment, services and supplies covered by the Policy. Coverage under the Participating Organization’s Policy must remain continuously in force from the date of the Covered Accident or Sickness until the date treatment, services or supplies are received for them to be a Covered Expense. A Covered Expense is deemed to be incurred on the date such treatment, service or supply, that gave rise to the expense or the charge, was rendered or obtained.

  • Management Expenses means the Management Expenses more particularly described in Clause 10.1;

  • Medical Expenses means those expenses that an Insured Person has necessarily and actually incurred for medical treatment on account of Illness or Accident on the advice of a Medical Practitioner, as long as these are no more than would have been payable if the Insured Person had not been insured and no more than other hospitals or doctors in the same locality would have charged for the same medical treatment.

  • Approved Operating Expenses means Operating Expenses incurred by Borrower or by any Manager on Borrower’s behalf (excluding any Restricted Payments) which (i) are included in the Approved Annual Budget for the current calendar month, (ii) are for real estate taxes, insurance premiums, electric, gas, oil, water, sewer or other utility service to the Properties, (iii) are for Management Fees, or (iv) have been approved in writing by Lender as Approved Operating Expenses; provided, however, that Approved Operating Expenses shall also include, for any calendar month in which Operating Expenses exceed the Monthly Operating Expense Budgeted Amount, the amount of such excess Operating Expenses up to and not to exceed ten percent (10%) of the Monthly Operating Expense Budgeted Amount for such calendar month as to which Borrower provides to Lender a reasonably detailed explanation of the reasons for and expenditures resulting in Operating Expenses exceeding the Monthly Operating Expense Amount.

  • Program Costs means all necessary and incidental costs of providing program services.

  • Marketing Costs which means such reasonable charge for marketing of ores and concentrates sold or of concentrates tolled as is consistent with generally accepted industry marketing practices;

  • Independent expenditure means an expenditure by a person:

  • Exploration Expenditures means the sum of:

  • Development Fee means a fee for the packaging of a Property, including negotiating and approving plans, and undertaking to assist in obtaining zoning and necessary variances and necessary financing for the Property, either initially or at a later date.

  • Annual Operating Expenses for the Class means and will consist only of the following operating expenses of the Series for the Class that are, under generally accepted accounting principles, accruable and deductible from the Series’ assets with respect to the Class for the calendar year involved: (i) investment advisory fees, if any; (ii) Rule 12b-1 distribution fees, if any; and (iii) custodian fees, shareholder servicing fees, administrative and office facilities expenses, professional fees, trustees’ fees and any other operating expenses of the Series with respect to the Class that are recorded or includable in the Series’ statement of operations in accordance with generally accepted accounting principles. Notwithstanding the provisions of the immediately preceding sentence, the Series’ “Annual Operating Expenses” for the Class do not include interest and dividends on securities sold short, amortization of organization expenses, taxes, brokerage commissions, litigation and indemnification expenses or any costs or expenses of or for the Series with respect to the Class that are “extraordinary” as determined under generally accepted accounting principles (see Accounting Principles Board Opinion No. 30). Very truly yours, ROYCE & ASSOCIATES, LLC By: /s/ Xxxx X. Xxxxxxxxx Xxxx X. Xxxxxxxxx Chief Operating Officer ACCEPTED: THE ROYCE FUND By: /s/ Xxxx X. Xxxxxxxxx Xxxx X. Xxxxxxxxx Vice President [ROYCE & ASSOCIATES, LLC LETTERHEAD] December 31, 2006 The Royce Fund 0000 Xxxxxx xx xxx Xxxxxxxx Xxx Xxxx, XX 00000 Re: Fee Waiver and Expense Reimbursement - Royce Micro-Cap Fund (Service Class) Gentlemen: Reference is made to the Investment Advisory Agreement dated October 1, 2001 (the “Agreement”) by and between The Royce Fund (the “Fund”) on behalf of Royce Micro-Cap Fund (the “Series”) and Royce & Associates (the “Adviser”). Notwithstanding the provisions of Section 4 (Compensation of the Adviser) of the Agreement, the Adviser hereby waives compensation for services provided by it under the Agreement for the calendar year ending December 31, 2007, and/or agrees to reimburse expenses relating to such calendar year to the Series with respect to the Class in an amount, if any, necessary so that the Series’ “Annual Operating Expenses” for its Service Class of shares (the “Class”) are not more than 1.66% of the Class’ average net assets for such calendar year. The Adviser hereby also waives compensation for services provided by it under the Agreement to the Series with respect to the Class, and/or agrees to reimburse expenses to the Series with respect to the Class for each subsequent calendar year through the year ending December 31, 2015 (but not for any calendar year thereafter) in an amount, if any, necessary so that the Series’ Annual Operating Expenses for the Class are not more than 1.99% of the Class’ average net assets for such calendar year. The Adviser’s obligations to reimburse the Series with respect to the Class hereunder will not apply for any period when the Adviser is not rendering services to such Series under the Agreement.

  • Transition Expenses The reasonable costs (including reasonable attorneys’ fees) of the Backup Servicer incurred in connection with the transferring the servicing obligations under this Agreement and amending this Agreement to reflect such transfer in an amount not to exceed $100,000.

  • Total Development Cost means the total of all costs incurred in the completion of a Development, all of which shall be subject to the review and approval by the Credit Underwriter and the Corporation pursuant to this rule chapter, and as further described in Rule 67-48.0075, F.A.C.

  • Development Cost means the total of all costs incurred in the completion of a Development excluding Developer Fee, operating deficit reserves, and total land cost as typically shown in the Development Cost line item on the development cost pro forma.

  • Qualified Project Costs shall have the meaning given to it in the Regulatory Agreement.

  • Direct Costs means the sum of the following:

  • Routine Patient Costs means all health care services that are otherwise covered under the Group Contract for the treatment of cancer or other Life-threatening Condition that is typically covered for a patient who is not enrolled in an Approved Clinical Trial.

  • Eligible Expenditures means expenditures in respect of the reasonable cost of goods, works and services required for the Project and to be financed out of the proceeds of the Loan allocated from time to time to the eligible Categories in accordance with the provisions of Schedule 1 to this Agreement; and

  • Reimbursable Expenses means all assignment-related costs [such as travel, translation, report printing, secretarial expenses, subject to specified maximum limits in the Contract].